CHIX:RICHTt (Hungary)
Â
Ordinary Shares
Ft
6,575
(0%)
Jul 18
Business Description
Chemical Works of Gedeon Richter PLC
ISIN : HU0000123096
Share Class Description:
CHIX:RICHTt: Ordinary SharesCompare
Compare
Traded in other countries / regions
RICHTER.Hungary0QFP.UKRIG2.GermanyCHWGR.LuxembourgGEDSF.USA IPO Date
2018-11-05Description
Chemical Works of Gedeon Richter PLC is a pharmaceutical company. The company focuses on the development and manufacture of gynaecological, cardiovascular, and central nervous system products. It manufactures medicines including original, generic and licensed products for treatment in the therapeutic area. The group is active in two business segments namely, the Pharma segment comprising Women's Healthcare, Neuropsychiatry, Biotechnology, General Medicine, and Other pharma; and the Others segment includes the remaining wholesale and retail business of the Group and all other activities. The company operates internationally.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 9.46 | |||||
| Equity-to-Asset | 0.82 | |||||
| Debt-to-Equity | 0.02 | |||||
| Debt-to-EBITDA | 0.1 | |||||
| Interest Coverage | 3.46 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 6.44 | |||||
| Beneish M-Score | -2.26 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 11.4 | |||||
| 3-Year EBITDA Growth Rate | 21.9 | |||||
| 3-Year EPS without NRI Growth Rate | 20.5 | |||||
| 3-Year Book Growth Rate | 13.1 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 9.96 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 19.49 |
Momentum Rank
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.49 | |||||
| Quick Ratio | 3.08 | |||||
| Cash Ratio | 1.27 | |||||
| Days Inventory | 579.94 | |||||
| Days Sales Outstanding | 196.07 | |||||
| Days Payable | 147.93 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Payout Ratio | 0.58 | |||||
| 3-Year Dividend Growth Rate | 24.2 | |||||
| 3-Year Average Share Buyback Ratio | 0.6 | |||||
| Shareholder Yield % | 4.47 |
Profitability Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 69.26 | |||||
| Operating Margin % | 29.51 | |||||
| Net Margin % | 31.38 | |||||
| EBITDA Margin % | 49.9 | |||||
| FCF Margin % | 24.26 | |||||
| ROE % | 10.87 | |||||
| ROA % | 8.84 | |||||
| ROIC % | 8.66 | |||||
| 3-Year ROIIC % | 25.62 | |||||
| ROC (Joel Greenblatt) % | 27.35 | |||||
| ROCE % | 13.89 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 13.49 | |||||
| Forward PE Ratio | 4.56 | |||||
| PE Ratio without NRI | 13.68 | |||||
| Shiller PE Ratio | 14.03 | |||||
| Price-to-Owner-Earnings | 29.73 | |||||
| PEG Ratio | 0.52 | |||||
| PS Ratio | 4.23 | |||||
| PB Ratio | 1.39 | |||||
| Price-to-Tangible-Book | 1.85 | |||||
| Price-to-Free-Cash-Flow | 17.45 | |||||
| Price-to-Operating-Cash-Flow | 14.68 | |||||
| EV-to-EBIT | 8.68 | |||||
| EV-to-EBITDA | 7.66 | |||||
| EV-to-Revenue | 3.82 | |||||
| EV-to-FCF | 15.76 | |||||
| Price-to-GF-Value | 0.98 | |||||
| Price-to-Projected-FCF | 1.12 | |||||
| Price-to-DCF (Earnings Based) | 0.34 | |||||
| Price-to-DCF (FCF Based) | 1.13 | |||||
| Price-to-Median-PS-Value | 1.78 | |||||
| Price-to-Peter-Lynch-Fair-Value | 1.05 | |||||
| Price-to-Graham-Number | 0.87 | |||||
| Price-to-Net-Current-Asset-Value | 4.37 | |||||
| Earnings Yield (Greenblatt) % | 11.52 | |||||
| FCF Yield % | 5.74 | |||||
| Forward Rate of Return (Yacktman) % | 16.77 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Chemical Works of Gedeon Richter PLC Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil Ft) | 440,285 | ||
| EPS (TTM) (Ft) | 756 | ||
| Beta | -0.05 | ||
| 3-Year Sharpe Ratio | -24.08 | ||
| 3-Year Sortino Ratio | -3.43 | ||
| Volatility % | 7.74 | ||
| 14-Day RSI | - | ||
| 14-Day ATR (Ft) | - | ||
| 20-Day SMA (Ft) | 6575 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (Ft) | 6575 - 6575 | ||
| Shares Outstanding (Mil) | 182.38 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Chemical Works of Gedeon Richter PLC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Chemical Works of Gedeon Richter PLC Stock Events
| Event | Date | Price (Ft) | ||
|---|---|---|---|---|
| No Event Data | ||||
Chemical Works of Gedeon Richter PLC Frequently Asked Questions
What is Chemical Works of Gedeon Richter PLC(CHIX:RICHTt)'s stock price today?
The current price of CHIX:RICHTt is Ft6575.00. The 52 week high of CHIX:RICHTt is Ft6575.00 and 52 week low is Ft6575.00.
When is next earnings date of Chemical Works of Gedeon Richter PLC(CHIX:RICHTt)?
The next earnings date of Chemical Works of Gedeon Richter PLC(CHIX:RICHTt) is .
Does Chemical Works of Gedeon Richter PLC(CHIX:RICHTt) pay dividends? If so, how much?
Chemical Works of Gedeon Richter PLC(CHIX:RICHTt) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers